Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical 20% Azelaic Acid Versus 4% Hydroquinone in Epidermal Melasma: A Randomized Controlled Trial

NCT07327983 is registered in ClinicalTrials.gov with Gujranwala medical college District Headquarters Hospital, Gujranwala as lead sponsor.

NCT NCT07327983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07327983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical 20% Azelaic Acid Versus 4% Hydroquinone in Epidermal Melasma: A Randomized Controlled Trial
Lead sponsor
Gujranwala medical college District Headquarters Hospital, Gujranwala
Phase
Not applicable
Overall status
Completed
Start date
May 4, 2025
Completion date
November 3, 2025
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma, melasma (facial melasma)